H. Pater

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

R. Collins, G. Hankey, A. Keech, 1998, The New England journal of medicine.

Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study

A. Keech, H. White, P. Glasziou, 2016, Circulation.

Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long‐term Intervention with Pravastatin in Ischaemic Disease (LIPID) study

A. Tonkin, D. Hunt, D. Magliano, 2003, Australian and New Zealand journal of public health.